Today is 2018-11-20

Trial search
Filter Options
Public title Scientific title Subject ID
Registration Status Registration number Secondary ID
       More Options

16 trials have been registered

Historical versions Registration number Public title Type Registration time
Historical Versions ChiCTR1800017569

Clinical trial of cladribine combined with cytarabine and liposomal doxorubicin in remission induction of high-risk or refractory acute myeloid leukemia

Xinqiao Hospital

  2018/08/04
Historical Versions ChiCTR1800017310

A randomized controlled trial for arsenic trioxide combined with ESHAP (etoposide+methylprednisolone+cytarabine+cisplatin) in the treatment of relapsed or refractory ALK+ anaplastic large cell lymphoma.

Tongji Hospital Affiliated to Tongji University School of Medicine

Interventional 2018/07/23
Historical Versions ChiCTR1800015922

A randomized multicenter clinical trial of medium dose cytarabine based CEAC regimen combined with cratripine preconditioning in the treatment of high-risk NHL

The Second Affiliated Hospital of Army Medical University

Interventional 2018/04/29
Historical Versions ChiCTR1800015871

A clinical study of chidamide with FLAG (fludarabine+cytarabine+G-CSF) in the treatment of relapsed /refractory /first cycle induced non-remission acute myeloid leukemia

Anhui Provincial Hospital

  2018/04/25
Historical Versions ChiCTR1800014975

High dose cytarabine plus temozolomide for refractory/relapsed primary diffuse large B cell lymphoma of central nervous system: a prospective clinical study

North Huashan Hospital, Fudan University

Observational 2018/02/25
Historical Versions ChiCTR-INR-17012015

Evaluation of the efficacy and safety of single-dose PEG-rhG-CSF, cytarabine and aclaramycin regimens for relapse or refractory acute myeloid leukemia

Xinqiao Hospital, Chongqing

Interventional 2017/05/31
Historical Versions ChiCTR-OPC-16010166

Efficacy and safety of cladribine in combination with G-CSF, low-dose cytarabine and aclarubicin in patients with refractory/relapsed acute myeloid leukemia: a phase 2, single center, single arm study

Sun Yat-sen University Cancer Center

Observational 2016/12/15
Historical Versions ChiCTR-OIC-15007583

Efficacy and safety of cladribine in combination with G-CSF, low-dose cytarabine and aclarubicin in newly diagnosed elderly patients with acute myeloid leukemia: a phase 2, single center, single arm study

Sun Yat-sen University Cancer Center

Observational 2015/12/16
Historical Versions ChiCTR-ONC-11001700

The study of decitabine combination with aclarubicin and cytarabine and granulocyte colony-stimulating factor on the outcome of elderly patients with acute myeloid leukaemia

The First Affiliated Hospital of Nanjing Medical Hospital, Jiangsu Province Hospital

Observational 2011/09/28
Historical Versions ChiCTR-OPN-15006417

High dose Methotrexate (MTX) followed by Etoposide, Cytarabine (EA), stem cell support and temozolomide maintenance therapy in patients with newly diagnosed Primary Central Nervous System B-cell Lymphoma

Department of Hematology, Peking Union Medical College Hospital

Observational 2015/05/13
First 1 2 Next Last